According to Orthofix Medical 's latest financial reports and stock price the company's current Operating Margin is -2.90%. At the end of 2021 the company had an Operating Margin of -2.91%.
Year | Operating Margin | Change |
---|---|---|
2021 | -2.91% | 3109.86% |
2020 | -0.09% | -98.46% |
2019 | -5.88% | -216.42% |
2018 | 5.05% | -39.78% |
2017 | 8.39% | 80.69% |
2016 | 4.64% | 116.37% |
2015 | 2.15% | -30.71% |
2014 | 3.10% | -358.81% |
2013 | -1.20% | -106.69% |
2012 | 17.89% | 400.43% |
2011 | 3.58% | -72.13% |
2010 | 12.83% | 74.89% |
2009 | 7.33% | -112.92% |
2008 | -56.77% | -1981.14% |
2007 | 3.02% | 74.5% |
2006 | 1.73% | -94.33% |
2005 | 30.49% | 73.53% |
2004 | 17.57% | -8.97% |
2003 | 19.30% | -15.43% |
2002 | 22.82% | 28.52% |
2001 | 17.76% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Stryker Corporation SYK | 16.21% | -658.97% | ๐บ๐ธ USA |
NuVasive NUVA | 4.35% | -250.00% | ๐บ๐ธ USA |
Smith & Nephew
SNN | 4.50% | -255.17% | ๐ฌ๐ง UK |
Globus Medical GMED | 23.83% | -921.72% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.